References
- Adams HP Jr, Davis PH, Leira EC, Chang KC, Bendixen BH, Clarke WR, et al. : Baseline NIH Stroke Scale score strongly predicts outcome after stroke : A report of the Trial of Org 10172 in Acute Stroke Treatment (TOAST). Neurology 53 : 126-131, 1999 https://doi.org/10.1212/WNL.53.1.126
- Biller J, Love BB, Marsh EE 3rd, Jones MP, Knepper LE, Jiang D, et al. : Spontaneous improvement after acute ischemic stroke. A pilot study. Stroke 21 : 1008-1012, 1990 https://doi.org/10.1161/01.STR.21.7.1008
- Escolar G, Bozzo J, Maragall S : Argatroban : a direct thrombin inhibitor with reliable and predictable anticoagulant actions. Drugs Today (Barc) 42 : 223-236, 2006 https://doi.org/10.1358/dot.2006.42.4.953588
- Furlan A, Higashida R, Wechsler L, Gent M, Rowley H, Kase C, et al. : Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study : a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 282 : 2003-2011, 1999 https://doi.org/10.1001/jama.282.21.2003
- Gubitz G, Counsell C, Sandercock P, Signorini D : Anticoagulants for acute ischemic stroke. Cochrane Database Syst Rev : 2000;(2) : CD000024
- Hosomi N, Naya T, Kohno M, Kobayashi S, Koziol JA; Japan Standard Stroke Registry Study Group : Efficacy of anti-coagulant treatment with argatroban on cardioembolic stroke. J Neurol 254 : 605-612, 2007 https://doi.org/10.1007/s00415-006-0365-y
- Jorgensen HS, Nakayama H, Reith J, Raaschou HO, Olsen TS : Factors delaying hospital admission in acute stroke : the Copenhagen Stroke Study. Neurology 47 : 383-387, 1996 https://doi.org/10.1212/WNL.47.2.383
- Jovin TG, Gupta R, Uchino K, Jungreis CA, Wechsler LR, Hammer MD, et al. : Emergent stenting of extracranial internal carotid artery occlusion in acute stroke has a high revascularization rate. Stroke 36 : 2426-2430, 2005 https://doi.org/10.1161/01.STR.0000185924.22918.51
- Kawai H, Yuki S, Sugimoto J, Tamao Y : Effects of a thrombin inhibitor, argatroban, on ischemic brain damage in the rat distal middle cerebral artery occlusion model. J Pharmacol Exp Ther 278 : 780- 785, 1996
- Keris V, Rudnicka S, Vorona V, Enina G, Tilgale B, Fricbergs J : Combined intraarterial/intravenous thrombolysis for acute ischemic stroke. AJNR Am J Neuroradiol 22 : 352-358, 2001
- Kobayashi S, Kitani M, Yamaguchi S, Suzuki T, Okada K, Tsunematsu T : Effects of an antithrombotic agent (MD-805) on progressing cerebral thrombosis. Thromb Res 53 : 305-317, 1989 https://doi.org/10.1016/0049-3848(89)90105-9
- Kobayashi S, Tazaki Y : Effect of the thrombin inhibitor argatroban in acute cerebral thrombosis. Semin Thromb Hemost 23 : 531-534, 1997 https://doi.org/10.1055/s-2007-996131
- LaMonte MP : Argatroban in thrombotic stroke. Pathophysiol Haemost Thromb 32 Suppl 3 : 39-45, 2002 https://doi.org/10.1159/000069108
- LaMonte MP, Brown PM, Hursting MJ : Alternative parenteral anticoagulation with argatroban, a direct thrombin inhibitor. Expert Rev Cardiovasc Ther 3 : 31-41, 2005 https://doi.org/10.1586/14779072.3.1.31
- LaMonte MP, Nash ML, Wang DZ, Woolfenden AR, Schultz J, Hursting MJ, et al. : Argatroban anticoagulation in patients with acute ischemic stroke (ARGIS-1) : a randomized, placebo-controlled safety study. Stroke 35 : 1677-1682, 2004 https://doi.org/10.1161/01.STR.0000131549.20581.ba
- Morris DC, Zhang L, Zhang ZG, Lu M, Berens KL, Brown PM, et al. : Extension of the therapeutic window for recombinant tissue plasminogen activator with argatroban in a rat model of embolic stroke. Stroke 32 : 2635-2640, 2001 https://doi.org/10.1161/hs1101.097390
- Noser EA, Shaltoni HM, Hall CE, Alexandrov AV, Garami Z, Cacayorin ED, et al. : Aggressive mechanical clot disruption : a safe adjunct to thrombolytic therapy in acute stroke? Stroke 36 : 292- 296, 2005 https://doi.org/10.1161/01.STR.0000152331.93770.18
- Ok YC, Park SK, Cho KY, Lim JS, Lee RS : Epidemiology and characteristics of recurrent stroke : The occurrence type of restroke is similar as previous stroke. J Korean Neurosurg Soc 41 : 224-229, 2007 https://doi.org/10.3340/jkns.2007.41.4.224
- Park HS, Kang MJ, Huh JT : Recent epidemiological trends of stroke. J Korean Neurosurg Soc 43 : 16- 20, 2008 https://doi.org/10.3340/jkns.2008.43.1.16
- Sandercock PA, Counsell C, Kamal AK : Anticoagulants for acute ischemic stroke. Cochrane Database Syst Rev : 2008 oct 8;CD000024
- Saposnik G, Di Legge S, Webster F, Hachinski V : Predictors of major neurologic improvement after thrombolysis in acute stroke. Neurology 65 : 1169-1174, 2005 https://doi.org/10.1212/01.wnl.0000180687.75907.4b
- Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rtPA Stroke Study Group : N Engl J Med 333 : 1581-1587, 1995 https://doi.org/10.1056/NEJM199512143332401
- Toni D, Lorenzano S, Sacchetti ML, Fiorelli M, De Michele M, Principe M : Specific therapies for ischaemic stroke : rTPA and others. Neurol Sci 26 Suppl 1 : S26-S28, 2005 https://doi.org/10.1007/s10072-005-0399-4
- Urabe T, Tanaka R, Noda K, Mizuno Y : Anticoagulant therapy with a selective thrombin inhibitor for acute cerebral infarction : usefulness of coagulation markers for evaluation of efficacy. J Thromb Thrombolysis 13 : 155-160, 2002 https://doi.org/10.1023/A:1020426906956
- Wityk RJ, Pessin MS, Kaplan RF, Caplan LR : Serial assessment of acute stroke using the NIH Stroke Scale. Stroke 25 : 362-365, 1994 https://doi.org/10.1161/01.STR.25.2.362
- Yoneda Y, Mori E, Uehara T, Yamada O, Tabuchi M : Referral and care for acute ischemic stroke in a Japanese tertiary emergency hospital. Eur J Neurol 8 : 483-488, 2001 https://doi.org/10.1046/j.1468-1331.2001.00275.x
Cited by
- Discovery, development and effectiveness of coagulation-inhibiting drugs for stroke therapy vol.6, pp.4, 2010, https://doi.org/10.1517/17460441.2011.563732